Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

Bridging the Gap between Practice and Research: Forging Partnerships with Community-Based Drug and Alcohol Treatment.

Institute of Medicine (US) Committee on Community-Based Drug Treatment; Lamb S, Greenlick MR, McCarty D, editors.

Washington (DC): National Academies Press (US); 1998.

2.

Site matters: multisite randomized trial of motivational enhancement therapy in community drug abuse clinics.

Ball SA, Martino S, Nich C, Frankforter TL, Van Horn D, Crits-Christoph P, Woody GE, Obert JL, Farentinos C, Carroll KM; National Institute on Drug Abuse Clinical Trials Network.

J Consult Clin Psychol. 2007 Aug;75(4):556-67. Erratum in: J Consult Clin Psychol. 2009 Apr;77(2):336.

3.

The cost-effectiveness of four treatments for marijuana dependence.

Olmstead TA, Sindelar JL, Easton CJ, Carroll KM.

Addiction. 2007 Sep;102(9):1443-53. Epub 2007 Jul 23.

4.

One small step for manuals: Computer-assisted training in twelve-step facilitation.

Sholomskas DE, Carroll KM.

J Stud Alcohol. 2006 Nov;67(6):939-45.

5.

Developing adaptive treatment strategies in substance abuse research.

Murphy SA, Lynch KG, Oslin D, McKay JR, TenHave T.

Drug Alcohol Depend. 2007 May;88 Suppl 2:S24-30. Epub 2006 Oct 23.

6.

The use of contingency management and motivational/skills-building therapy to treat young adults with marijuana dependence.

Carroll KM, Easton CJ, Nich C, Hunkele KA, Neavins TM, Sinha R, Ford HL, Vitolo SA, Doebrick CA, Rounsaville BJ.

J Consult Clin Psychol. 2006 Oct;74(5):955-66.

7.

Evidence-based youth psychotherapies versus usual clinical care: a meta-analysis of direct comparisons.

Weisz JR, Jensen-Doss A, Hawley KM.

Am Psychol. 2006 Oct;61(7):671-89.

PMID:
17032068
8.

Training and fidelity monitoring of behavioral interventions in multi-site addictions research.

Baer JS, Ball SA, Campbell BK, Miele GM, Schoener EP, Tracy K.

Drug Alcohol Depend. 2007 Mar 16;87(2-3):107-18. Epub 2006 Oct 4. Review.

9.

Cost-effectiveness of prize-based incentives for stimulant abusers in outpatient psychosocial treatment programs.

Olmstead TA, Sindelar JL, Petry NM.

Drug Alcohol Depend. 2007 Mar 16;87(2-3):175-82. Epub 2006 Sep 12.

10.

National survey of psychotherapy training in psychiatry, psychology, and social work.

Weissman MM, Verdeli H, Gameroff MJ, Bledsoe SE, Betts K, Mufson L, Fitterling H, Wickramaratne P.

Arch Gen Psychiatry. 2006 Aug;63(8):925-34.

PMID:
16894069
11.

Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial.

Anton RF, O'Malley SS, Ciraulo DA, Cisler RA, Couper D, Donovan DM, Gastfriend DR, Hosking JD, Johnson BA, LoCastro JS, Longabaugh R, Mason BJ, Mattson ME, Miller WR, Pettinati HM, Randall CL, Swift R, Weiss RD, Williams LD, Zweben A; COMBINE Study Research Group.

JAMA. 2006 May 3;295(17):2003-17.

PMID:
16670409
12.

Medication augmentation after the failure of SSRIs for depression.

Trivedi MH, Fava M, Wisniewski SR, Thase ME, Quitkin F, Warden D, Ritz L, Nierenberg AA, Lebowitz BD, Biggs MM, Luther JF, Shores-Wilson K, Rush AJ; STAR*D Study Team.

N Engl J Med. 2006 Mar 23;354(12):1243-52.

13.

Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression.

Rush AJ, Trivedi MH, Wisniewski SR, Stewart JW, Nierenberg AA, Thase ME, Ritz L, Biggs MM, Warden D, Luther JF, Shores-Wilson K, Niederehe G, Fava M; STAR*D Study Team.

N Engl J Med. 2006 Mar 23;354(12):1231-42.

14.

Effects of lower-cost incentives on stimulant abstinence in methadone maintenance treatment: a National Drug Abuse Treatment Clinical Trials Network study.

Peirce JM, Petry NM, Stitzer ML, Blaine J, Kellogg S, Satterfield F, Schwartz M, Krasnansky J, Pencer E, Silva-Vazquez L, Kirby KC, Royer-Malvestuto C, Roll JM, Cohen A, Copersino ML, Kolodner K, Li R.

Arch Gen Psychiatry. 2006 Feb;63(2):201-8.

PMID:
16461864
15.

Training, supervision and quality monitoring of the COMBINE Study behavioral interventions.

Miller WR, Moyers TB, Arciniega L, Ernst D, Forcehimes A.

J Stud Alcohol Suppl. 2005 Jul;(15):188-95; discussion 168-9.

PMID:
16223070
16.

Effect of prize-based incentives on outcomes in stimulant abusers in outpatient psychosocial treatment programs: a national drug abuse treatment clinical trials network study.

Petry NM, Peirce JM, Stitzer ML, Blaine J, Roll JM, Cohen A, Obert J, Killeen T, Saladin ME, Cowell M, Kirby KC, Sterling R, Royer-Malvestuto C, Hamilton J, Booth RE, Macdonald M, Liebert M, Rader L, Burns R, DiMaria J, Copersino M, Stabile PQ, Kolodner K, Li R.

Arch Gen Psychiatry. 2005 Oct;62(10):1148-56.

PMID:
16203960
17.

Motivational interviewing to improve treatment engagement and outcome in individuals seeking treatment for substance abuse: a multisite effectiveness study.

Carroll KM, Ball SA, Nich C, Martino S, Frankforter TL, Farentinos C, Kunkel LE, Mikulich-Gilbertson SK, Morgenstern J, Obert JL, Polcin D, Snead N, Woody GE; National Institute on Drug Abuse Clinical Trials Network.

Drug Alcohol Depend. 2006 Feb 28;81(3):301-12. Epub 2005 Sep 28.

19.

Behavioral therapies for drug abuse.

Carroll KM, Onken LS.

Am J Psychiatry. 2005 Aug;162(8):1452-60. Review.

20.

A multi-center randomized trial of buprenorphine-naloxone versus clonidine for opioid detoxification: findings from the National Institute on Drug Abuse Clinical Trials Network.

Ling W, Amass L, Shoptaw S, Annon JJ, Hillhouse M, Babcock D, Brigham G, Harrer J, Reid M, Muir J, Buchan B, Orr D, Woody G, Krejci J, Ziedonis D; Buprenorphine Study Protocol Group.

Addiction. 2005 Aug;100(8):1090-100. Erratum in: Addiction. 2006 Sep;101(9):1374.

Items per page

Supplemental Content

Write to the Help Desk